Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
Sun Pharma Advanced Research Company Limited Identifier:
First received: March 16, 2009
Last updated: March 8, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)